Oakridge International Limited (OAK.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -761.24 Thousand AUD | -555.62% |
| 2023 | -116.11 Thousand AUD | 78.13% |
| 2022 | -531.03 Thousand AUD | -188.03% |
| 2021 | 603.21 Thousand AUD | 554.39% |
| 2020 | -132.75 Thousand AUD | 96.43% |
| 2019 | -3.71 Million AUD | 58.45% |
| 2018 | -8.94 Million AUD | 24.53% |
| 2017 | -11.85 Million AUD | -284.01% |
| 2016 | -3.08 Million AUD | -5.58% |
| 2015 | -2.92 Million AUD | -231.7% |
| 2014 | -881.4 Thousand AUD | 75.75% |
| 2013 | -3.63 Million AUD | 87.18% |
| 2012 | -28.34 Million AUD | -1389.29% |
| 2011 | -1.9 Million AUD | 49.75% |
| 2010 | -3.78 Million AUD | -126.07% |
| 2009 | -1.67 Million AUD | 26.83% |
| 2008 | -2.28 Million AUD | -402.8% |
| 2007 | -455.35 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q4 | -301.43 Thousand AUD | 0.0% |
| 2024 Q2 | -459.8 Thousand AUD | 0.0% |
| 2024 FY | -761.24 Thousand AUD | -555.62% |
| 2023 Q4 | 40.42 Thousand AUD | 0.0% |
| 2023 Q2 | -156.53 Thousand AUD | 0.0% |
| 2023 FY | -116.11 Thousand AUD | 78.13% |
| 2022 Q2 | -403.42 Thousand AUD | 0.0% |
| 2022 Q4 | -127.6 Thousand AUD | 0.0% |
| 2022 FY | -531.03 Thousand AUD | -188.03% |
| 2021 Q4 | -270.56 Thousand AUD | 0.0% |
| 2021 FY | 603.21 Thousand AUD | 554.39% |
| 2021 Q2 | 873.78 Thousand AUD | 0.0% |
| 2020 FY | -132.75 Thousand AUD | 96.43% |
| 2020 Q2 | 533.49 Thousand AUD | 0.0% |
| 2020 Q4 | -666.25 Thousand AUD | 0.0% |
| 2019 FY | -3.71 Million AUD | 58.45% |
| 2019 Q4 | -3.63 Million AUD | 0.0% |
| 2019 Q2 | -12.19 Thousand AUD | 0.0% |
| 2018 Q2 | -5.68 Million AUD | 0.0% |
| 2018 FY | -8.94 Million AUD | 24.53% |
| 2018 Q4 | -3.26 Million AUD | 0.0% |
| 2017 FY | -11.85 Million AUD | -284.01% |
| 2017 Q2 | -3.92 Million AUD | 0.0% |
| 2017 Q4 | -7.93 Million AUD | 0.0% |
| 2016 Q3 | -1.3 Million AUD | -167.27% |
| 2016 FY | -3.08 Million AUD | -5.58% |
| 2016 Q4 | -2.6 Million AUD | -100.0% |
| 2016 Q1 | -243.23 Thousand AUD | 0.0% |
| 2016 Q2 | -486.46 Thousand AUD | -100.0% |
| 2015 FY | -2.92 Million AUD | -231.7% |
| 2014 FY | -881.4 Thousand AUD | 75.75% |
| 2013 FY | -3.63 Million AUD | 87.18% |
| 2012 FY | -28.34 Million AUD | -1389.29% |
| 2011 FY | -1.9 Million AUD | 49.75% |
| 2010 FY | -3.78 Million AUD | -126.07% |
| 2009 FY | -1.67 Million AUD | 26.83% |
| 2008 FY | -2.28 Million AUD | -402.8% |
| 2007 FY | -455.35 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alcidion Group Limited | -8.41 Million AUD | 90.956% |
| Artrya Limited | -14 Million AUD | 94.563% |
| Beamtree Holdings Limited | -5.1 Million AUD | 85.091% |
| Cogstate Limited | 8.31 Million AUD | 109.153% |
| Careteq Limited | -2.66 Million AUD | 71.437% |
| Doctor Care Anywhere Group PLC | -10.04 Million AUD | 92.425% |
| Emyria Limited | -11.45 Million AUD | 93.355% |
| Global Health Limited | -1.31 Million AUD | 41.983% |
| HITIQ Limited | -3.2 Million AUD | 76.246% |
| Intelicare Holdings Limited | -2.25 Million AUD | 66.306% |
| ImExHS Limited | -4.19 Million AUD | 81.842% |
| Mach7 Technologies Limited | -7.97 Million AUD | 90.449% |
| MedAdvisor Limited | 792.13 Thousand AUD | 196.101% |
| Opyl Limited | -3.13 Million AUD | 75.682% |
| PainChek Limited | -8.3 Million AUD | 90.837% |
| Pro Medicus Limited | 82.79 Million AUD | 100.919% |
| Resonance Health Limited | 169.3 Thousand AUD | 549.636% |
| Singular Health Group Ltd | -4.92 Million AUD | 84.542% |
| Total Brain Limited | -14.78 Million AUD | 94.85% |